Autopsy report · NCT03228953

Pharmacogenomic Testing in Major Depressive Disorder

“Investigator retired.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years before it stopped.
• 38 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Columbia University

Sponsor type

University, hospital or other

Conditions

Major Depressive Disorder

Interventions

Pharmacogenomic testing

Participants

38

Sites

1

Countries

United States

Trials that died the same way

• Trial of Art Therapy During Cognitive Processing Therapy for PTSD
  “Investigator has retired.” (96% match in meaning)
• Target Sign vs Palpation for Radial Arterial Line Placement
  “Principal Investigator retired” (84% match in meaning)
• Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis
  “Original investigator left this institution, replacement investigator retired.” (83% match in meaning)
• Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy
  “Investigator Retirement” (82% match in meaning)
• The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer
  “Principal Investigator retired before study completed.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.